Anew Labs
An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
$290MFunding
ParticipantGV
Gaorong Ventures
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Jan 1, 2026
Gaorong Ventures, also identified as Gaorong Capital, is the investment organization connected to Axoft and Moonwalk financing histories.
Recorded funding activity
Moonwalk develops medicines targeting fat-tissue pathways, while Axoft develops implanted brain-computer interfaces. The recorded activity also includes Anew’s combination of molecular models and experimental biology for drug discovery. These companies pursue different clinical technologies.
- Rounds participated in
- 6
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $1.4B 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in this selectionMoonwalk Biosciences
Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.
$70MSeries B
ParticipantDogotix Inc. (XPeng Robotics)
Dogotix Inc. is the holding company for XPeng’s robotics business, which develops humanoid and other general-purpose robotic systems.
$900MConditional Series A subscription agreements
ParticipantEvoken
Evoken builds AI tools for image, design and video production.
~$300MSeries B+
ParticipantAxoft
Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders
$55MSeries A
Role not disclosedPulnovo Medical
Develops interventional therapies for pulmonary hypertension and heart failure
$100MStrategic
Role not disclosed